Consolidated Portfolio Review Corp’s Nuveen Real Asset Income & Growth Fund JRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-106,198
Closed -$1.37M 452
2025
Q1
$1.37M Sell
106,198
-38,094
-26% -$484K 0.22% 111
2024
Q4
$1.75M Buy
144,292
+6,223
+5% +$81.4K 0.28% 98
2024
Q3
$1.89M Buy
138,069
+3,131
+2% +$40.1K 0.42% 57
2024
Q2
$1.64M Buy
134,938
+37,331
+38% +$432K 0.38% 66
2024
Q1
$1.16M Buy
97,607
+19,577
+25% +$227K 0.3% 86
2023
Q4
$915K Buy
78,030
+8,388
+12% +$90.2K 0.21% 117
2023
Q3
$740K Sell
69,642
-6,649
-9% -$74.5K 0.18% 136
2023
Q2
$871K Sell
76,291
-4,557
-6% -$52K 0.21% 120
2023
Q1
$949K Buy
+80,848
New +$980K 0.26% 98

Other funds holding JRI

Consolidated Portfolio Review Corp's JRI Position: Q2 2025 in Review

Consolidated Portfolio Review Corp sold out of Nuveen Real Asset Income & Growth Fund (JRI) in Q2 2025, closing a stake of 106,198 shares — an estimated $1.37M sold.

Consolidated Portfolio Review Corp first reported a position in JRI in Q1 2023 and held it in 9 quarters. The position peaked at $1.89M in Q3 2024. 73 funds tracked by Wall St. Rank hold JRI as of Q2 2025.

  • Consolidated Portfolio Review Corp reported no remaining Nuveen Real Asset Income & Growth Fund position as of Q2 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 106,198 Nuveen Real Asset Income & Growth Fund shares in Q2 2025, an estimated $1.37M.
  • Consolidated Portfolio Review Corp first reported a position in Nuveen Real Asset Income & Growth Fund in Q1 2023 and held it in 9 quarters.
  • Consolidated Portfolio Review Corp's Nuveen Real Asset Income & Growth Fund position peaked at $1.89M in Q3 2024.
  • 73 funds tracked by Wall St. Rank held Nuveen Real Asset Income & Growth Fund as of Q2 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q2 2025, filed 18 Jul 2025.